US House adopts FDA user fee bill with ease; reconciliation with Senate ahead
This article was originally published in SRA
Executive Summary
The US House of Representatives on 30 May swiftly adopted its version of the Food and Drug Administration user fee bill in a somewhat anticlimactic 387-5 vote, without the fire-and-brimstoning that came in the Senate, although that chamber, too, easily passed its legislation, 96-1, with very little debate – a rare occurrence in Washington, especially lately1,2.
Register for our free email digests: